1h Free Analyst Time
The hemostats and tissue sealants market is forecasted to grow by USD 3.35 billion during 2023-2028, accelerating at a CAGR of 11.79% during the forecast period. The report on the hemostats and tissue sealants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high use of hemostats and tissue sealants in surgeries, increasing prevalence of chronic diseases and related risk factors, and technological advances in global hemostats and tissue sealants market.
The hemostats and tissue sealants market is segmented as below:
By Product
- Hemostats
- Tissue sealants and adhesives
- Fibrin sealants
By End-user
- Hospitals
- Ambulatory surgical centers
- Homecare settings
- Others
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the hemostats and tissue sealants market covers the following areas:
- Hemostats and tissue sealants market sizing
- Hemostats and tissue sealants market forecast
- Hemostats and tissue sealants market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global hemostats and tissue sealants market: Advanced Medical Solutions Group Plc, B.Braun SE, Baxter International Inc., Becton Dickinson and Co., BioCer Entwicklungs GmbH, Cardinal Health Inc., CSL Ltd., CuraMedical BV, Hemostasis LLC, Integra Lifesciences Corp., Johnson and Johnson Services Inc., KATSAN KATGUT SANAYI VE TICARET A.S, Medtronic Plc, Pfizer Inc., Smith and Nephew plc, Stryker Corp., Teijin Ltd., Teleflex Inc., Tricol Biomedical Inc., and Vivostat AS.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing R&D focus on novel hemostats and tissue sealants."
According to the report, one of the major drivers for this market is the high use of hemostats and tissue sealants in surgeries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advanced Medical Solutions Group Plc
- B.Braun SE
- Baxter International Inc.
- Becton Dickinson and Co.
- BioCer Entwicklungs GmbH
- Cardinal Health Inc.
- CSL Ltd.
- CuraMedical BV
- Hemostasis LLC
- Integra Lifesciences Corp.
- Johnson and Johnson Services Inc.
- KATSAN KATGUT SANAYI VE TICARET A.S
- Medtronic Plc
- Pfizer Inc.
- Smith and Nephew plc
- Stryker Corp.
- Teijin Ltd.
- Teleflex Inc.
- Tricol Biomedical Inc.
- Vivostat AS
